Matches in SemOpenAlex for { <https://semopenalex.org/work/W4318775872> ?p ?o ?g. }
- W4318775872 endingPage "179" @default.
- W4318775872 startingPage "162" @default.
- W4318775872 abstract "The occurrence of severe bleeding syndrome because of the PML-RARα fusion protein is a life-threatening event in APL. This protein destabilizes homeostasis, maturation, remodeling, and tissue regeneration in addition to hampering the maintenance and differentiation of hematopoietic cells into different lineages, fixing cells in the promyelocyte stage. APL is a classic example of how effective targeted therapy is and, therefore, how important the use of such therapy is to the overall survival of patients, which in this case is represented by the use of ATRA/ATO. Despite that, about 10% of cases of APL patients demonstrate resistance to treatment. Facing this scenario, we point out promising target therapies such as those recommended by the NCCN and Leukemia Net. Since this is such a heterogeneous molecular disease, it is of great importance to understand how important combined chemotherapy, target therapy, immune-based therapy, and combined therapies are in the survival of these APL patients." @default.
- W4318775872 created "2023-02-02" @default.
- W4318775872 creator A5002197953 @default.
- W4318775872 creator A5043367199 @default.
- W4318775872 creator A5087455622 @default.
- W4318775872 date "2023-02-01" @default.
- W4318775872 modified "2023-10-17" @default.
- W4318775872 title "Acute Promyelocytic Leukemia (APL): A Review of the Classic and Emerging Target Therapies towards Molecular Heterogeneity" @default.
- W4318775872 cites W1996468867 @default.
- W4318775872 cites W2006439627 @default.
- W4318775872 cites W2007397931 @default.
- W4318775872 cites W2014506560 @default.
- W4318775872 cites W2109653033 @default.
- W4318775872 cites W2112549441 @default.
- W4318775872 cites W2114188307 @default.
- W4318775872 cites W2117101794 @default.
- W4318775872 cites W2153610769 @default.
- W4318775872 cites W2322688915 @default.
- W4318775872 cites W2337302783 @default.
- W4318775872 cites W2561289538 @default.
- W4318775872 cites W2567135770 @default.
- W4318775872 cites W2599780351 @default.
- W4318775872 cites W2606935378 @default.
- W4318775872 cites W2736930944 @default.
- W4318775872 cites W2768202893 @default.
- W4318775872 cites W2803179025 @default.
- W4318775872 cites W2883812891 @default.
- W4318775872 cites W2884323144 @default.
- W4318775872 cites W2902301444 @default.
- W4318775872 cites W2912682470 @default.
- W4318775872 cites W2914671276 @default.
- W4318775872 cites W2918095490 @default.
- W4318775872 cites W2941630251 @default.
- W4318775872 cites W2962844727 @default.
- W4318775872 cites W2965068570 @default.
- W4318775872 cites W2968563688 @default.
- W4318775872 cites W2969845879 @default.
- W4318775872 cites W2970958272 @default.
- W4318775872 cites W2972427995 @default.
- W4318775872 cites W2995123606 @default.
- W4318775872 cites W2997334784 @default.
- W4318775872 cites W3009639630 @default.
- W4318775872 cites W3009751715 @default.
- W4318775872 cites W3010783628 @default.
- W4318775872 cites W3011467845 @default.
- W4318775872 cites W3037802405 @default.
- W4318775872 cites W3086339132 @default.
- W4318775872 cites W3095201154 @default.
- W4318775872 cites W3095552675 @default.
- W4318775872 cites W3114932971 @default.
- W4318775872 cites W3126011689 @default.
- W4318775872 cites W3131928636 @default.
- W4318775872 cites W3138670192 @default.
- W4318775872 cites W3175459412 @default.
- W4318775872 cites W3183621780 @default.
- W4318775872 cites W4200435835 @default.
- W4318775872 cites W4200461731 @default.
- W4318775872 cites W4200518376 @default.
- W4318775872 cites W4224290890 @default.
- W4318775872 cites W4280552588 @default.
- W4318775872 cites W4281779421 @default.
- W4318775872 cites W4283027744 @default.
- W4318775872 cites W4285043725 @default.
- W4318775872 cites W4286241304 @default.
- W4318775872 cites W4289522686 @default.
- W4318775872 cites W4297389715 @default.
- W4318775872 doi "https://doi.org/10.3390/futurepharmacol3010012" @default.
- W4318775872 hasPublicationYear "2023" @default.
- W4318775872 type Work @default.
- W4318775872 citedByCount "3" @default.
- W4318775872 countsByYear W43187758722023 @default.
- W4318775872 crossrefType "journal-article" @default.
- W4318775872 hasAuthorship W4318775872A5002197953 @default.
- W4318775872 hasAuthorship W4318775872A5043367199 @default.
- W4318775872 hasAuthorship W4318775872A5087455622 @default.
- W4318775872 hasBestOaLocation W43187758721 @default.
- W4318775872 hasConcept C104317684 @default.
- W4318775872 hasConcept C109159458 @default.
- W4318775872 hasConcept C119157973 @default.
- W4318775872 hasConcept C121608353 @default.
- W4318775872 hasConcept C126322002 @default.
- W4318775872 hasConcept C203014093 @default.
- W4318775872 hasConcept C2776601000 @default.
- W4318775872 hasConcept C2778461978 @default.
- W4318775872 hasConcept C2779134260 @default.
- W4318775872 hasConcept C2781121885 @default.
- W4318775872 hasConcept C2781230642 @default.
- W4318775872 hasConcept C28328180 @default.
- W4318775872 hasConcept C502942594 @default.
- W4318775872 hasConcept C54355233 @default.
- W4318775872 hasConcept C60644358 @default.
- W4318775872 hasConcept C71924100 @default.
- W4318775872 hasConcept C86803240 @default.
- W4318775872 hasConceptScore W4318775872C104317684 @default.
- W4318775872 hasConceptScore W4318775872C109159458 @default.
- W4318775872 hasConceptScore W4318775872C119157973 @default.
- W4318775872 hasConceptScore W4318775872C121608353 @default.
- W4318775872 hasConceptScore W4318775872C126322002 @default.